Deverra Therapeutics
Seattle, US · Founded 2019
Biotech
Founders & leadership
CW
Colleen W DelaneyExecutive Officer
MW
Michael W YurkowskyExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements$2.4MraisedSep 2023 · 1 investors · Biotechnology
Rule 506(b)$75KraisedAug 2020 · 2 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.